Gastrointestinal Side Effects The side effect rates are fairly similar, but that doesnt mean that each drug will affect everyone equally
Interest in this next-generation compound has surged thanks to its unique triple-agonist mechanism and impressive clinical trial results
Very rare cases of intestinal obstruction have been reported which can be a serious health problem that requires surgery
The MHRA has not approved any GLP-1 receptor agonist for use below the labelled doses, and this approach falls outside current prescribing guidelines
8 Therefore, given the increasing burden of lean MASLD in some populations and the benefits of GLP-1RA in weight management, more clinical attention is warranted
It helps regulate appetite, stabilize blood sugar, and signal fullness to your brain which is why it's at the center of the biggest shift in metabolic health today